[1]
Breccia, M. et al. 2016. Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia. Mediterranean Journal of Hematology and Infectious Diseases. 8, (Feb. 2016), e2016016. DOI:https://doi.org/10.4084/mjhid.2016.016.